Levaskar Sustained Release Tablet 150 mg (Levamisole)

Adult dose

For adults, take 1 tablet twice daily, once in the morning and once in the evening. This medicine should be swallowed whole and should not be divided or chewed.

This medicine should not be used in patients who have had hypersensitivity reactions to any component of this medicine. During the use of this medicine, adverse reactions such as gastrointestinal disturbances, infections, and muscle pain may occur, and if symptoms worsen, consultation with a doctor is required. Serious allergic reactions such as shock or anaphylaxis may rarely occur, so if abnormal symptoms appear, the administration should be stopped immediately, and a hospital visit is necessary. Issues such as liver dysfunction or decreased blood cell count have also been reported, so regular examinations may be necessary. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medicine, and breastfeeding individuals are advised to avoid breastfeeding while using this medication. Safety for children and adolescents has not been sufficiently confirmed, so caution is required. Elderly individuals may have reduced bodily functions, so they should be especially careful about adverse reactions such as gastrointestinal symptoms. This medicine should be kept out of reach of children, and transferring to another container should be avoided as it could compromise quality.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor (severe allergic reactions), high fever accompanied by severe rash, blisters, skin peeling, pain in mucous membranes of the mouth/eyes (severe cutaneous adverse reactions), shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever (respiratory problems), yellowing of the skin or eyes (jaundice), extreme lethargy (liver abnormalities), sudden and severe

Mild side effects

Gastrointestinal disturbances (nausea, indigestion, constipation, diarrhea, abdominal bloating, upper abdominal pain, vomiting, heartburn, abdominal pain, belching, taste changes), infections and infestations (nasopharyngitis, tonsillitis, epididymitis), musculoskeletal and connective tissue disorders (muscle pain, joint pain, muscle weakness), neurological disorders (dizziness, headache, drowsiness, migraine), skin and subcutaneous tissue disorders (dry skin, eczema, pruritus, rash, itching, drug eruption-like eczema)

This medicine may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature. This will help to safely preserve the efficacy of the medication.

Appearance

White oblong sustained release tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle